Orserdu and Weight increased - a phase IV clinical study of FDA data

Summary:

Weight increased is reported as a side effect among people who take Orserdu (elacestrant dihydrochloride), especially for people who are female, 60+ old, have been taking the drug for 6 - 12 months also take Vitamin D3, and have Breast cancer metastatic.

The phase IV clinical study analyzes which people have Weight increased when taking Orserdu. It is created by eHealthMe based on reports of 4,608 people who have side effects when taking Orserdu from the FDA, and is updated regularly.

What is Orserdu?

Orserdu has active ingredients of elacestrant dihydrochloride. eHealthMe is studying from 4,608 Orserdu users. Check the latest studies of Orserdu.

What is Weight increased?

Weight increased is found to be associated with 2,886 drugs and 3,952 conditions by eHealthMe. Check the latest studies of Weight increased.

On Jul, 16, 2026

4,608 people reported to have side effects when taking Orserdu.
Among them, 31 people (0.67%) have Weight increased.

Among these 31 people:

How long have people been on Orserdu when they have Weight increased? *

What is the gender of people who have Weight increased when taking Orserdu? *

female: 100 %
male: 0.0 %

What is the age of people who have Weight increased when taking Orserdu? *

What are other drugs people take besides Orserdu? *

What are other side effects people have besides Weight increased? *

Nausea (feeling of having an urge to vomit): 12 people, 38.71%
Fatigue (feeling of tiredness): 10 people, 32.26%
Headache (pain in head): 5 people, 16.13%
Disease Progression: 5 people, 16.13%
Constipation: 5 people, 16.13%
Bone Pain: 5 people, 16.13%
Nausea And Vomiting: 4 people, 12.90%
Joint Pain: 4 people, 12.90%
Pain: 4 people, 12.90%
Peripheral Swelling: 4 people, 12.90%

What are the existing conditions these people have? *

Panic Disorder: 2 people, 6.45%
Breast Cancer Metastatic: 2 people, 6.45%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 1 person, 3.23%
Pneumonia: 1 person, 3.23%
Neuralgia (pain in one or more nerves): 1 person, 3.23%
Nasopharyngitis (inflammation of the nasopharynx): 1 person, 3.23%
Breast Cancer Stage Iv: 1 person, 3.23%
Blood Iron Decreased: 1 person, 3.23%

* Approximation only. Some reports may have incomplete information.

Do you take Orserdu and have Weight increased?

- Check whether Weight increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Orserdu:

Orserdu (4,608 reports)

Weight increased treatments and more:

Weight increased (279,369 reports)

Browse all side effects of Orserdu:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Weight increased:

Weight increased (2,886 drugs)

Browse all the conditions that are associated with Weight increased:

Weight increased (3,952 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on elacestrant dihydrochloride (the active ingredients of Orserdu) and Orserdu (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.